3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
4
Neoplasms
3
Leiomyoma
2
Vomiting
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Periampullary Carcinoma Nos
1
Pediatric Crohn's disease
1
Pain
1
Obesity
1
Nausea
1
Myasthenia Gravis
1
Motor Activity
1
Menstruation Disturbances
1
Memory Disorders
1
Hyperinsulinism
1
Hyperandrogenism
1
Hot Flashes
1
Fatigue
1
Cognitive Dysfunction
1
Cancer Pain
1
Anemia
1
Interventions
Dexamethasone
23
Ondansetron
12
Palonosetron
11
Aprepitant
9
Granisetron
7
Olanzapine
5
ramosetron
3
netupitant, palosentron drug combination
3
casopitant
3
Radiotherapy
3
fosaprepitant
2
Thalidomide
2
Prochlorperazine
2
Electroacupuncture
2
Dronabinol
2
Analgesia
2
Acupressure
2
sinomenine
1
netupitant
1
lerisetron
1
dolasetron
1
dexamethasone acetate
1
Tropisetron
1
Therapeutics
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Metoclopramide
1
Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Vomiting
×
Sugars
×
Clear all
NCT00206440
2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3
Terminated
43 enrolled
5 charts